Tonix Pharmaceuticals Reports First Quarter 2015 Financial Results and Clinical Update

Go back to Tonix Pharmaceuticals Reports First Quarter 2015 Financial Results and Clinical Update

Tonix Pharmaceuticals (TNXP) Misses Q1 EPS by 17c

May 11, 2015 6:26 AM EDT

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q1 EPS of ($0.71), $0.17 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

... More